Vaccines for other neonatal infections: are group B streptococcal infections vaccine-preventable?
Preliminary studies suggest that a pentavalent group B streptococcus conjugate vaccine, given in a single dose at 32-34 weeks gestation, would prevent approximately 90% of early and late onset neonatal and most postpartum maternal group B streptococcus infections.
Center for Infectious Diseases and Microbiology, Institute of Clinical Pathology and Medical Research, Westmead Hospital, and National Center for Immunization Research and Surveillance, University of Sydney, Sydney, Australia. ggilbert@mail.usyd.edu.au
G L
GL
Gilbert
D019072:Antibiotic Prophylaxis; D005260:Female; D006801:Humans; D007114:Immunization; D007231:Infant, Newborn; D011247:Pregnancy; D013290:Streptococcal Infections / Q000517:prevention & control*; D022541:Streptococcal Vaccines / Q000276:immunology*; D013292:Streptococcus agalactiae / Q000276:immunology*; D018074:Vaccines, Conjugate / Q000276:immunology
D022541:Streptococcal Vaccines; D018074:Vaccines, Conjugate